Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
up to 15-20% increase IMP dehydrogenase activity
-
DMSO at a final concentration of 30% v/v added into the assay mixture, increases the activity up to 120% of the control enzyme activity
-
the addition of 10% (v/v) dimethyl sulfoxide increases the activity by 161.2%
-
activates the whole enzyme activity
-
the whole enzyme activity is the highest using DMSO among the organic solvents tested, and its optimal concentration is 2.5% v/v
-
about 145% activity at 5% (v/v)
-
maximum conversion of 5-epiaristolochene to capsidiol activity is observed at final concentrations of 2-5% (v/v) dimethyl sulfoxide
-
5% DMSO, 180% activation
-
activity is enhanced in the presence of 10-50% (v/v), the activity in 30% (v/v) DMSO is 170% of the activity in water and the enantioselectivity towards L-DOPA decreases by 40%
-
activity is increased about 2fold in the presence of 5% DMSO (v/v)
-
activates at up to 50% v/v
-
103.19% activity at 20% (v/v)
maximal activity at 0.16% (v/v)
about 130% activity at 2.5% (v/v) DMSO
-
about 115% activity at 2.5% (v/v) DMSO
-
induction of enzyme expression, erythroleukemia cells
-
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
8.5fold increase in activity with Gly-Ala-Gln-Phe-Ser-Lys-Thr-Ala-Arg-Arg, 10fold with Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys-Arg and 7fold increase with Gly-Asn-Ala-Ser-Ser-Ile-Lys-Lys-Lys
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
activation requires a serine in the peptide substrate
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
strong activation of enzyme in hepatocytes
activation, in the absence of methanol, inhibits in the presence of 0.05% sarkosyl
activation, in the absence of methanol, inhibits in the presence of 0.05% sarkosyl
activation, in the absence of methanol, inhibits in the presence of 0.05% sarkosyl
20% DMSO has a positive effect on the GTase rate of PBP1B, particularly at the higher Triton X-100 concentration of 0.2%. At higher Triton X-100 concentration in the presence of 20% DMSO the stimulation of PBP1B by LpoB is only 1.6fold
20% DMSO has a positive effect on the GTase rate of PBP1B, particularly at the higher Triton X-100 concentration of 0.2%. At higher Triton X-100 concentration in the presence of 20% DMSO the stimulation of PBP1B by LpoB is only 1.6fold
20% DMSO has a positive effect on the GTase rate of PBP1B, particularly at the higher Triton X-100 concentration of 0.2%. At higher Triton X-100 concentration in the presence of 20% DMSO the stimulation of PBP1B by LpoB is only 1.6fold
high concentration (35%) of dimethylsulfoxide is necessary for maximal enzyme activity
-
increases the enzyme's hydrolytic activity
-
activates alpha and beta isoenzymes from liver
activates alpha and beta isoenzymes from liver
activates isoform from kidney and isoform MAT-III from liver
activates isoform from kidney and isoform MAT-III from liver
activates the beta isozyme from liver 13-15fold
activates the beta isozyme from liver 13-15fold
weak activation of the alpha isozyme from liver
weak activation of the alpha isozyme from liver
20%, 9fold increase in activity, probably due to crowding effect
-
1.0%, activation to 160% of the original activity
-
20%, 1.8fold stimulation
-
protects arginine kinase from inactivation losing its native tertiary conformation and aggregation in the presence of guanidine hydrochloride
-
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
10% (v/v), activity and enantioselectivity of mutant enzyme V138G toward (S)-ketoprofen ethyl ester is greatly increased. 10% and 20% (v/v) decreases activity of wild-type and mutant enzyme V138G/L200R
-
optimal activation at 3.5% v/v with an increase in kcat of 20-30%, no dramatic changes in conformation of the enzyme at 3.5% v/v DMSO and 50-80°C, but significant changes at small DMSO concentrations
-
10% v/v, 500% of initial activity, 30% v/v, 110% of initial activity
-
21% increase of activity at 50% (v/v) dimethyl sulfoxide, at 30°C
-
about 130% activity at 1 mM
-
1.4fold activation at 2.5% v/v
-
concentrated solution increases the enzyme activity 5fold, maximal activity at a water content of 0.5-1% w/w
-
64% activation of recombinant refolded enzyme at 10% v/v, no effect at 30% v/v
-
activates 20-70% at 20% v/v
-
activates both extracellular isozymes 1.73fold
-
activates 14% at 40% v/v
-
activates 9% at 40% v/v
-
increase in enzyme activity (130%) is observed at 25% v/v DMSO although at a higher concentration (50%), DMSO decreases enzyme activity to 72%
-
21% increase of activity at 50% (v/v) dimethyl sulfoxide, at 30°C
-
activates by 10% at 25% v/v
-
the activity is enhanced by addition of 10% (v/v) dimethylsulfoxide
-
enzyme activity increases to 136% in the presence of 10% (v/v) DMSO
-
about 160% activity at 25%(v/v)
-
cosolvent DMF improves the transglycosylation yields in concentrations of 2%-10% v/v, whereas at higher concentrations (>30% v/v DMSO), it turns out to be deleterious for the process
-
10% (v/v), native enzyme is activated to 102.3% of control, recombinant enzyme is activated to 106.4% of control, beta-glucosidase activity
-
10% v/v, 106% of initial activity, 20% v/v, 112.6% of initial activity
-
catalytic activity is promoted in the presence of DMSO. DMSO affects the oligomerization state, causing the enzyme dimers to associate into tetramers
-
0.5%, 108% of initial activtiy
-
11% activation at 10% w/v
-
activation to 111.5% at 5 mM
-
6.58% increase of activity at 2 mM
-
up to 25%, enhances activity
-
the activity progressively increases with increase in dimethyl sulfoxide concentration up to 5% (v/v)
-
activity using substrates containing 2% v/v DMSO is 5% higher than that using substrate containing no DSMO
-
increases enzyme activity up to 2fold with increasing concentration
-
about 140% activity at 2 mM
-
induces conformational changes, stimulates with SecY s substrate, at concentration up to 20% v/v, slightly inhibitory with casein as a substrate
-
increases the catalytic efficiency on the ring cyclization reaction, but not on the ring hydrolysis
-
112% activity at 10% (v/v) DMSO
cosolvent stabilizes tubulin
-
highest activity between 20% and 30% dimethyl sulfoxide (v/v) with a peak at 25%. Records of pH-activity profiles at different dimethyl sulfoxide concentrations and constant ionic strength (100 mM) reveals a strong influence of the cosolvent on the activity of BAL, and indicates a cross effect on the optimal pH with a shift of profiles to the alkaline milieu. Correlation between the dependency on pH and dimethyl sulfoxide concentration is due to interaction of dimethyl sulfoxide with the amino acid side chain Glu50 in the catalytic site of the biocatalyst
-
water-miscible, enhances phosphotransferase activity
-
activates the whole enzyme activity
-
levels of samp3ylated proteins and samp3 transcripts are increased by the addition of dimethyl sulfoxide to aerobically growing cells
-
activates in absence of the activator acetylglutamate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
50% (v/v), 29% loss of activity
50% (v/v), 29% loss of activity
50% (v/v), 29% loss of activity
50% (v/v), 29% loss of activity
DMSO inhibits isozyme ADH2-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode; DMSO inhibits isozymes ADH1C-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode, no inhibition is detected with isozyme ADH3; DMSO inhibits isozymes ADH4-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode
DMSO inhibits isozyme ADH2-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode; DMSO inhibits isozymes ADH1C-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode, no inhibition is detected with isozyme ADH3; DMSO inhibits isozymes ADH4-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode
DMSO inhibits isozyme ADH2-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode; DMSO inhibits isozymes ADH1C-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode, no inhibition is detected with isozyme ADH3; DMSO inhibits isozymes ADH4-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode
DMSO inhibits isozyme ADH2-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode; DMSO inhibits isozymes ADH1C-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode, no inhibition is detected with isozyme ADH3; DMSO inhibits isozymes ADH4-catalysed oxidation in an uncompetitive mode and reduction in a mixed mode
32.6% residual activity at 5% (v/v)
-
8.4% residual activity at 40% (v/v)
-
complete inhibition in buffer without NaCl, 60% inhibition in buffer with 600 mM NaCl
-
complete inhibition by 50% DMSO
-
the enzyme is inactivated by the addition of 50% (v/v) after incubation for 24 h at 37°C
-
the enzyme is inactivated by the addition of 50% (v/v) of dimethylsulfoxide after incubation for 24 h at 37°C
-
10%, 11% loss of activity
-
11% inhibition at a ratio of 1:2 with enzyme solution
-
1 h, 10% loss of activity by 20% (v/v), 40% loss of activity by 50% (v/v)
-
50% (v/v), 85% inhibition
-
10%, 50% loss of the original activity
-
40% (v/v) 50% inhibition
-
mutant enzyme V159E/N398D
-
the native enzyme shows less than 5% residual activity in the presence of DMSO
-
50% inhibition at 20%, 90% inhibition at 30%, pH 5.0, 25°C
-
50% inhibition at 20%, 90% inhibition at 30%, pH 5.0, 25°C
-
less than 10% residual activity at 40% (v/v)
76.0% residual activity at 30% (v/v)
-
DMSO is hardly tolerated by the enzyme (the residual activity drops to near 0% with 2% (v/v) DMSO)
DMSO is hardly tolerated by the enzyme (the residual activity drops to near 0% with 2% (v/v) DMSO)
competitive inhibition at 16.6-66 mM, binding structure analysis by circular dichroism and fluorescence spectroscopy. Seven DMSO molecules interact with amino acids onthe surface of Renilla luciferase. Two of them interact with two catalytic residues (Glu144, His285), the rest of the DMSO molecules have specific interactions with the residues in the substrate binding site including Pro220, Phe180, and Phe261
inhibits slightly by 10% at 20% v/v
-
about 50% inhibition at 0.5 % (v/v)
-
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
CYP102A7 exhibits 50% of its initial activity in the presence of 26% dimethyl sulfoxide
conversion of 5-epiaristolochene to capsidiol activity is inhibited at concentrations above 10% (v/v) dimethyl sulfoxide
-
low concentrations of DMSO (lower than 3.5 M) lead to reversible mixed-type inhibition of the enzyme, 68.0% residual activity at 1.4 M, 52.6% residual activity at 2.1 M, 36.6% residual activity at 2.8 M, complete inhibition at 5.6 M
-
1-33% residual activity at 40% (v/v)
-
10% (v/v), 32% inhibition
-
68.04% residual activity at 50% (v/v)
-
irreversibly impairs the enzymatic activity at 30% v/v
irreversibly impairs the enzymatic activity at 30% v/v
in the presence of 4% (v/v) DMSO, Mycobacterium tubercolosis reductase activity is reduced by only 10%. It is recommended that the DMSO content in sets of inhibition assays should be kept at a constant with 4% (v/v) DMSO as the upper limit
-
DMSO competitively inhibits the methionine-sulfoxide reduction ability of MsrA (12% residual activity at 0.1% (v/v) DMSO) and inhibits the antioxidant function of MsrA in yeast cells, resulting in higher sensitivity to oxidative stress
-
competitive, about 82% inhibition at 1% v/v
-
more than 4% cause inhibition
-
20% inhibition at 40% v/v
-
in the presence of 0.05% N-lauroylsarcosine
in the presence of 0.05% N-lauroylsarcosine
in the presence of 0.05% N-lauroylsarcosine
2% v/v reduces enzyme activity in liver microsomes
-
2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes; 2% v/v reduces enzyme activity in liver microsomes
-
50% inhibition of isozyme UGT2B17 at 0.5%
-
about 22.9% decreased enzyme activity, 10%
-
98% residual activity at 5 mM
-
20% v/v, 43% inhibition
-
5 mM, 89% loss of activity
-
20% v/v, 62% inhibition
-
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
at 2% (v/v) DMSO isoform ARTD10 loses more than half of its activity; at 2% (v/v) DMSO isoform ARTD7 loses its activity completely
80% inhibition at 20% v/v
-
slight inhibition of gamma isoenzyme from kidney
slight inhibition of gamma isoenzyme from kidney
weak inhibition of liver isoenzyme
weak inhibition of liver isoenzyme
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%
40% inhibition at 20%, 70% inhibition at 30%; slight to moderate inhibition at 20-30%
-
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
complete inhibition at 0.4% (v/v)
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
67% inhibition of RNAse H activity at 10%
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
inhibition of DNA polymerase epsilon, stimulation of DNA polymerase delta
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
stimulates DNA polymerase alpha and delta, inhibits human DNA polymerase epsilon
50% inhibition at 10% v/v, no inhibition at 2.86% v/v
-
10% (v/v), activity and enantioselectivity of mutant enzyme V138G toward (S)-ketoprofen ethyl ester is greatly increased. 10% (v/v) and 20% (v/v) decreases activity of wild-type and mutant enzyme V138G/L200R
-
10% (w/v), 66% inhibition; 5% (v/v), 58% inhibition
-
22% inhibition of BioHs at 30%
-
30% v/v, 22% loss of activity
-
about 60% residual activity at 30% (v/v)
-
10 mM, 14% loss of activity; 16% inhibition at 10 mM
-
71% residual activity in the presence of 90% (v/v) dimethyl sulfoxide, after 60 min at 70°C
-
1 mM, 19% remaining activity
-
BTID-A, 54% inhibition at 1% w/v
-
49% inhibition at 75% v/v
-
85% inhibition at 10% (vol/vol)
-
increase in enzyme activity (130%) is observed at 25% v/v DMSO although at a higher concentration (50%), DMSO decreases enzyme activity to 72%
-
addition to the reaction mixture results in a dose-dependent inhibition of PAP1 activity, 25% loss of PAP1 activity at a 1% concentration
-
71% residual activity in the presence of 90% (v/v) dimethyl sulfoxide, after 60 min at 70°C
-
at 37°C, 5% completely inhibits activity
-
inhibits 20% at 20% v/v, and 31% at 50% v/v
-
inhibits enzyme activity at concentrations higher than 30% (v/v)
-
1 h incubation at 60°C, no loss of activity at 10% v/v DSMO, 40% loss at 20% v/v DSMO, and no activity at 50% v/v DSMO of the free enzyme. The immobilized enzyme retains 82% of the activity, independently of DSMO concentration after the exposure at high temperature
-
enzyme hydrolytic activity is not modified by addition of 2% v/v DMSO and is significantly diminished at DMSO concentration of 10% v/v. After 18 h incubation the yield of product is nervertheless increased by 2fold; hydrolytic activity tested with 1.8 mM hesperidin as substrate. Activity is not modified by addition of 2% (v/v) DMSO, but is significantly diminished when the concentration is increased up to 10% (v/v). Hydrolysis yield is increased upon addition of DMSO, with hesperetin final concentrations in the range of 0.47-0.95 mM after 18 h reaction
-
4% inhibition at 10% and 13% at 25%
-
inhibits 26% at 15% and 42% at 30%
-
30% 25% inhibition. 40% 47% inhibition. 50% 68% inhibition
-
10%, 21% inhibition. 25%, 85% inhibition
-
84% residual activity at 5% (v/v)
-
92.9% and 57% residual activity at 2.5 mM with 4-nitrophenyl beta-D-glucopyranoside and cellobioside as substrate, respectively
-
5 mM, no residual activity
-
80.8% residual activity at 10% (v/v)
-
30% v/v, 50% inhibition
-
the addition of organic solvent can enhance solubility of naringin dihydrochalcone, but it also decreases enzyme activity. Dimethyl sulfoxide, acetone and methanol decrease enzyme activity more seriously than that of ethanol. When necessary, ethanol as a co-solvent with quantity less than 5% (v/v) is ecommended to improve the hydrolysis reaction of naringin dihydrochalcone
-
1% (v/v), about 45% loss of activity, 5% (v/v), about 75% loss of activity
-
87.55% residual activity at 5% (v/v)
-
inhibits 10% and 40% at 5% and 10% v/v, respectively
-
the enzyme is inhibited by 30-50% (v/v) DMSO
-
10%, 18.3% loss of activity
-
79.3% residual activity at 5% (v/v)
-
about 40% residual activity at 10% (v/v)
-
about 45% residual activity at 10% (v/v)
-
10% (v/v), about% inhibition
-
reduces the activity by 42% at 6.25% v/v
-
13.9% inhibition at 4.2% v/v
-
15.1% inhibition at 4.2% v/v
-
13.9% inhibition at 4.2% v/v
-
15.1% inhibition at 4.2% v/v
-
inhibitory effect with more than 5% (v/v) dimethyl sulfoxide
-
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
catalytic activity decreases slightly with increasing dimethyl sulfoxide concentrations. At 2% (v/v) dimethyl sulfoxide, the proteolytic activity of UCH-L3 is reduced by ca. 5% in comparison to dimethyl sulfoxide-free conditions
10% DMSO decreases the activity to 85%. 30% DMSO reduces the activity to about 70%, and 50% DMSO reduces the activity to about 45%
-
catalytic activity of the protease decreases with increasing DMSO concentration
-
loss of 41-53% activity at 15-50% v/v after 24 h, loss of 21-48% activity after 1 h
-
the number of active sites of papain decreases with increasing concentration of dimethyl sulfoxide whereas the incubation time, in a buffer containing 3% dimethyl sulfoxide does not affect the number of active sites. A rapid decrease of the initial reaction rate, by up to 30%, is observed between 1 and 2% dimethyl sulfoxide
-
activity gradually decreased above 1.0% DMSO
-
1%, complete loss of activity
about 65% residual activity at 0.1 mM
-
in the presence of 10% (v/v) DMSO a significant decrease in activity to 40% is observed. In 25% (v/v) DMSO the enzyme maintains 20% of the activity. Activity is completely lost when the enzyme is exposed to DMSO at concentration above 35% (v/v)
in the presence of 10% (v/v) DMSO a significant decrease in activity to 40% is observed. In 25% (v/v) DMSO the enzyme maintains 20% of the activity. Activity is completely lost when the enzyme is exposed to DMSO at concentration above 35% (v/v)
in the presence of 10% (v/v) DMSO a significant decrease in activity to 40% is observed. In 25% (v/v) DMSO the enzyme maintains 20% of the activity. Activity is completely lost when the enzyme is exposed to DMSO at concentration above 35% (v/v)
presence of 2% dimethyl sulfoxide disrupts interactions of enzyme with substrate and thereby reduces activity by 70%
-
98.14% residual activity at 10 mM
-
induces conformational changes, stimulates with SecY as substrate, at concentration up to 20% v/v, slightly inhibitory with casein as a substrate
-
5% v/v, complete inhibition; complete inhibition at 5% (v/v)
-
low concentrations of DMSO, up to a maximum at 10%, enhance synthetic activity, while higher concentrations inhibit
-
inhibition up to 10%, v/v
-
15% (v/v),about 35% inhibition
-
5%, about 45% inhibition
-
at 12.5% (v/v) remaining activity, 131.26%, and 25% (v/v) remaining activity, 133.2%
-
about 15% activation at 2%
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.